 SEATTLE, April 07, 2022 GLOBE NEWSWIRE -- Nautilus Biotechnology, Inc. NASDAQ: NAUT; or Nautilus, a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the first quarter 2022 before market open on Tuesday, May 3rd, 2022. 